Hematologic adverse effects and efficacy monitoring in chronic Hepatitis C patients treated with interferon and ribavirin combination therapy

Ghazala Rafique; Allah Bukhsh; Asif Gul; Sonia Khiljee; Muhammad Ashraf; Muhammad Ovais Omer

doi:10.36721/pjps/30/1/01.01.2017/3608/011-016

original articles

Hematologic adverse effects and efficacy monitoring in chronic Hepatitis C patients treated with interferon and ribavirin combination therapy

Ghazala Rafique, Allah Bukhsh, Asif Gul, Sonia Khiljee, Muhammad Ashraf, Muhammad Ovais Omer

Vol. 30

Issue 1

Pages 11-16

Online Date: 02 Jan 2017

Published: 02 Jan 2017

DOI: 10.36721/pjps/30/1/01.01.2017/3608/011-016

Authors Abstract Related

Authors & Affiliations

Ghazala Rafique

Allah Bukhsh

Asif Gul

Sonia Khiljee

Muhammad Ashraf

Muhammad Ovais Omer

Abstract

180 million people are affected by chronic Hepatitis C Virus infection globally and more than 50 million in South East Asia

Keywords

Chronic Hepatitis C

ribavirin

anemia

interferon

end treatment response.

Metrics

PlumX Metrics

original articles

Hematologic adverse effects and efficacy monitoring in chronic Hepatitis C patients treated with interferon and ribavirin combination therapy

Ghazala Rafique, Allah Bukhsh, Asif Gul, Sonia Khiljee, Muhammad Ashraf, Muhammad Ovais Omer

Vol. 30

Issue 1

Pages 11-16

Online Date: 02 Jan 2017

Published: 02 Jan 2017

DOI: 10.36721/pjps/30/1/01.01.2017/3608/011-016

Authors Abstract Related

Authors & Affiliations

Ghazala Rafique

Allah Bukhsh

Asif Gul

Sonia Khiljee

Muhammad Ashraf

Muhammad Ovais Omer

Abstract

180 million people are affected by chronic Hepatitis C Virus infection globally and more than 50 million in South East Asia

Keywords

Chronic Hepatitis C

ribavirin

anemia

interferon

end treatment response.

Metrics

PlumX Metrics

Hematologic adverse effects and efficacy monitoring in chronic Hepatitis C patients treated with interferon and ribavirin combination therapy

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Hematologic adverse effects and efficacy monitoring in chronic Hepatitis C patients treated with interferon and ribavirin combination therapy

Authors & Affiliations

Abstract

Keywords

Metrics